Evidence map›Paper›PMID 19211618›Full record

ReviewThe oncologist2009

Management of mucin-producing cystic neoplasms of the pancreas.

Stefan Fritz, Andrew L Warshaw, Sarah P Thayer

Open access · bronzeAbstract readReview
In one paragraph

Review in The oncologist, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Preemptive surgery for premalignant foregut lesions.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2009
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease.Nature reviews. Gastroenterology & hepatology · 2012
    Review
  8. [Cystic tumors of the pancreas].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2010
    Review
  9. Cystic neoplasms of the pancreas.Surgical oncology clinics of North America · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Stefan FritzDepartment of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA.
Andrew L Warshaw
Sarah P Thayer
Massachusetts General Hospital · US

Funding

The Hedgehog Pathway and Pancreatic NeoplasiaK08DK071329 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI THAYER, SARAH P · 2004 to 2008
$660k
NIDDK NIH HHS K08 DK071329
6 · The paper itself

Abstract

During the last decade small lesions of the pancreas have been increasingly recognized in clinical practice. Among these lesions, mucin-producing cystic neoplasms represent a recently described and unique entity among pancreatic tumors. In 1996, the World Health Organization distinguished two different types of mucinous cystic tumors: intraductal papillary mucinous neoplasms (IPMNs) of the pancreas, which are characterized by mucin production, cystic dilation of the pancreatic ducts, and intrapapillary growth, and mucinous cystic neoplasms (MCNs), which are defined by ovarian-like stroma and in most cases do not communicate with pancreatic ducts. Further, IPMNs can be subdivided into main-duct type, mixed-type, and branch-duct type tumors. Older data did not distinguish among different subsets of cystic neoplasms of the pancreas, and consequently many databases were inconsistent. Histopathologically, both IPMNs and MCNs demonstrate a wide spectrum of cellular atypia ranging from mild mucinous hyperplasia to invasive adenocarcinoma. Because mucinous cystic neoplasms of the pancreas show significant differences in clinical behavior from patient to patient, knowledge of the clinicopathologic characteristics and natural history of specific subtypes of IPMNs and MCNs has become crucial for physicians working in the field of gastroenterology. The present work offers an overview of current and generally accepted clinical guidelines for the diagnosis and treatment of IPMNs and MCNs.

Indexed as

Carcinoma, Pancreatic DuctalCystadenocarcinoma, MucinousHumansMucinsPancreatic NeoplasmsMucins

Identifiers

PMID19211618
PMCPMC3806054
OpenAlexW2097440131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.